Surgical techniques for testicular nonseminomatous germ cell tumors metastatic to the mediastinum

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Since 1980, the author and his colleagues have performed over 400 thoracic surgical procedures to remove residual mediastinal disease after cisplatin-based chemotherapy in nearly 300 patients with testicular nonseminomatous germ cell tumors [6]. Presurgical planning is individualized and may require coordination with urologic and head and neck surgeons to minimize the overall number of surgical procedures while maximizing exposure. Careful and systematic dissection can remove teratomatous residual disease from major blood vessels and intrathoracic nerves with minimal morbidity. The operative mortality rate has been low (1%), which is not unexpected in these otherwise young and healthy patients. The 10-year survival rate has been 78% from the time of diagnosis with removal of benign residual mediastinal disease pathologically consisting of either necrosis or teratoma. This success justifies an aggressive thoracic surgical approach in these cases. Commonly, multiple surgical procedures are required to remove bilateral or multiple levels of residual mediastinal disease or disease that presents during long-term follow-up. Prolonged survival seems possible following the resection of limited areas of persistent nonseminomatous germ cell tumors or nonseminomatous germ cell tumor degeneration into non-germ cell cancer within the mediastinum. Salvage surgery to remove chemotherapy-refractory mediastinal disease represents a situation in which significantly poorer long-term survival is anticipated; however, an aggressive surgical approach is justified in select patients.

Original languageEnglish
Pages (from-to)749-768
Number of pages20
JournalChest Surgery Clinics of North America
Volume12
Issue number4
StatePublished - Nov 2002

Fingerprint

Mediastinal Diseases
Mediastinum
Thoracic Surgical Procedures
Mediastinal Neoplasms
Drug Therapy
Survival
Teratoma
Cisplatin
Blood Vessels
Dissection
Necrosis
Neck
Thorax
Survival Rate
Head
Morbidity
Mortality
Testicular Germ Cell Tumor
Nonseminomatous germ cell tumor

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this

@article{528214638d644c98ad0507c475359c78,
title = "Surgical techniques for testicular nonseminomatous germ cell tumors metastatic to the mediastinum",
abstract = "Since 1980, the author and his colleagues have performed over 400 thoracic surgical procedures to remove residual mediastinal disease after cisplatin-based chemotherapy in nearly 300 patients with testicular nonseminomatous germ cell tumors [6]. Presurgical planning is individualized and may require coordination with urologic and head and neck surgeons to minimize the overall number of surgical procedures while maximizing exposure. Careful and systematic dissection can remove teratomatous residual disease from major blood vessels and intrathoracic nerves with minimal morbidity. The operative mortality rate has been low (1{\%}), which is not unexpected in these otherwise young and healthy patients. The 10-year survival rate has been 78{\%} from the time of diagnosis with removal of benign residual mediastinal disease pathologically consisting of either necrosis or teratoma. This success justifies an aggressive thoracic surgical approach in these cases. Commonly, multiple surgical procedures are required to remove bilateral or multiple levels of residual mediastinal disease or disease that presents during long-term follow-up. Prolonged survival seems possible following the resection of limited areas of persistent nonseminomatous germ cell tumors or nonseminomatous germ cell tumor degeneration into non-germ cell cancer within the mediastinum. Salvage surgery to remove chemotherapy-refractory mediastinal disease represents a situation in which significantly poorer long-term survival is anticipated; however, an aggressive surgical approach is justified in select patients.",
author = "Kenneth Kesler",
year = "2002",
month = "11",
language = "English",
volume = "12",
pages = "749--768",
journal = "Thoracic Surgery Clinics",
issn = "1547-4127",
publisher = "W.B. Saunders Ltd",
number = "4",

}

TY - JOUR

T1 - Surgical techniques for testicular nonseminomatous germ cell tumors metastatic to the mediastinum

AU - Kesler, Kenneth

PY - 2002/11

Y1 - 2002/11

N2 - Since 1980, the author and his colleagues have performed over 400 thoracic surgical procedures to remove residual mediastinal disease after cisplatin-based chemotherapy in nearly 300 patients with testicular nonseminomatous germ cell tumors [6]. Presurgical planning is individualized and may require coordination with urologic and head and neck surgeons to minimize the overall number of surgical procedures while maximizing exposure. Careful and systematic dissection can remove teratomatous residual disease from major blood vessels and intrathoracic nerves with minimal morbidity. The operative mortality rate has been low (1%), which is not unexpected in these otherwise young and healthy patients. The 10-year survival rate has been 78% from the time of diagnosis with removal of benign residual mediastinal disease pathologically consisting of either necrosis or teratoma. This success justifies an aggressive thoracic surgical approach in these cases. Commonly, multiple surgical procedures are required to remove bilateral or multiple levels of residual mediastinal disease or disease that presents during long-term follow-up. Prolonged survival seems possible following the resection of limited areas of persistent nonseminomatous germ cell tumors or nonseminomatous germ cell tumor degeneration into non-germ cell cancer within the mediastinum. Salvage surgery to remove chemotherapy-refractory mediastinal disease represents a situation in which significantly poorer long-term survival is anticipated; however, an aggressive surgical approach is justified in select patients.

AB - Since 1980, the author and his colleagues have performed over 400 thoracic surgical procedures to remove residual mediastinal disease after cisplatin-based chemotherapy in nearly 300 patients with testicular nonseminomatous germ cell tumors [6]. Presurgical planning is individualized and may require coordination with urologic and head and neck surgeons to minimize the overall number of surgical procedures while maximizing exposure. Careful and systematic dissection can remove teratomatous residual disease from major blood vessels and intrathoracic nerves with minimal morbidity. The operative mortality rate has been low (1%), which is not unexpected in these otherwise young and healthy patients. The 10-year survival rate has been 78% from the time of diagnosis with removal of benign residual mediastinal disease pathologically consisting of either necrosis or teratoma. This success justifies an aggressive thoracic surgical approach in these cases. Commonly, multiple surgical procedures are required to remove bilateral or multiple levels of residual mediastinal disease or disease that presents during long-term follow-up. Prolonged survival seems possible following the resection of limited areas of persistent nonseminomatous germ cell tumors or nonseminomatous germ cell tumor degeneration into non-germ cell cancer within the mediastinum. Salvage surgery to remove chemotherapy-refractory mediastinal disease represents a situation in which significantly poorer long-term survival is anticipated; however, an aggressive surgical approach is justified in select patients.

UR - http://www.scopus.com/inward/record.url?scp=0036854789&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036854789&partnerID=8YFLogxK

M3 - Article

C2 - 12471876

AN - SCOPUS:0036854789

VL - 12

SP - 749

EP - 768

JO - Thoracic Surgery Clinics

JF - Thoracic Surgery Clinics

SN - 1547-4127

IS - 4

ER -